Exploring the association of ESR1 and ESR2 gene SNPs with polycystic ovary syndrome in human females: a comprehensive association study

• Published in: Journal of ovarian research 2024-01, Vol.17 (1), p.27-14, Article 27
• Main Authors: Muccee, Fatima, Ashraf, Naeem Mahmood, Razak, Suhail, Afsar, Tayyaba, Hussain, Nadia, Husain, Fohad Mabood, Shafique, Huma
• Format: Article
• Language: English
• Subjects: 17β-Estradiol; Acanthosis nigricans; Amino acids; Analysis; Bioinformatics; Coding sequence; Cytochrome; Estradiol; Estrogen Receptor alpha - genetics; Estrogen Receptor beta - genetics; Estrogen receptors; Female; Females; Follicles; Genes; Genetic aspects; Hirsutism; Hormones; Humans; Infertility; Insulin resistance; Localization; Mutation; Ovaries; Ovulation; Polycystic ovary syndrome; Polycystic Ovary Syndrome - genetics; Polymorphism; Polymorphism, Single Nucleotide; Protein structure; Proteins; Secondary structure; Single nucleotide polymorphisms; Single-nucleotide polymorphism; Stein-Leventhal syndrome; Sub-cellular localization; Type 2 diabetes
• ISSN: 1757-2215; 1757-2215
• DOI: 10.1186/s13048-023-01335-7

Polycystic Ovary Syndrome (PCOS) affects a significant proportion of human females worldwide and is characterized by hormonal, metabolic, and reproductive dysfunctions, including infertility, irregular menstrual cycles, acanthosis nigricans, and hirsutism. Mutations in the estrogen receptor genes ESR1 and ESR2, involved in normal follicular development and ovulation, can contribute to development of the PCOS. The present study focuses on investigating the potential correlation between single nucleotide polymorphisms (SNPs) of ESR1 and ESR2 genes and the incidence of this syndrome. For this study, SNPs in ESR1 and ESR2 genes were retrieved from the ENSEMBL database and analyzed for their effect on mutated proteins using different bioinformatics tools including SIFT, PolyPhen, CADD, REVEL, MetaLR, I-Mutant, CELLO2GO, ProtParam, SOPMA, SWISS-MODEL and HDDOCK. All the SNPs documented in the present study were deleterious. All the SNPs except rs1583384537, rs1450198518, and rs78255744 decreased protein stability. Two variants rs1463893698 and rs766843910 in the ESR2 gene altered the localization of mutated proteins i.e. in addition to the nucleus, proteins were also found in mitochondria and extracellular, respectively. SNPs rs104893956 in ESR1 and rs140630557, rs140630557, rs1596423459, rs766843910, rs1596405923, rs762454979 and rs1384121511 in ESR2 gene significantly changed the secondary structure of proteins (2D). SNPs that markedly changed 3D configuration included rs1554259481, rs188957694 and rs755667747 in ESR1 gene and rs1463893698, rs140630557, rs1596423459, rs766843910, rs1596405923, rs762454979 and rs1384121511 in ESR2 gene. Variants rs1467954450 (ESR1) and rs140630557 (ESR2) were identified to reduce the binding tendency of ESRα and β receptors with estradiol as reflected by the docking scores i.e. -164.97 and -173.23, respectively. Due to the significant impact on the encoded proteins, these variants might be proposed as biomarkers to predict the likelihood of developing PCOS in the future and for diagnostic purposes.